pharmaceutical investing Takeda and TiGenix Announce Results of Second Acceptance Period for the Voluntary and Conditional Public Takeover Bid
pharmaceutical investing Takeda and TiGenix Announce Results of First Acceptance Period for the Voluntary and Conditional Public Takeover Bid of TiGenix
Homerun Resources Inc. Files for Approval of $3 Million Financing; Updates $6 Million Institutional Financing
